TAK-994
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-994, covering 2023-12-26 to 2024-10-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy [Phase 2]